Clinical Trials Browser

Completed × NETWORK × prexasertib × Clear all

NCT02808650 2023-12-20

Prexasertib in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors

Phase 1 Completed

30 enrolled 16 charts

Central Nervous System Neoplasms